| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3654538
Max Phase: Preclinical
Molecular Formula: C28H28F3N5O
Molecular Weight: 507.56
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CCCN(CCc5ccccc5C(F)(F)F)C4)cc23)ccn1
Standard InChI: InChI=1S/C28H28F3N5O/c1-18-15-20(10-12-32-18)26-23-16-21(8-9-25(23)34-35-26)27(37)33-22-6-4-13-36(17-22)14-11-19-5-2-3-7-24(19)28(29,30)31/h2-3,5,7-10,12,15-16,22H,4,6,11,13-14,17H2,1H3,(H,33,37)(H,34,35)/t22-/m1/s1
Standard InChI Key: VCOYRCZLGMNSQN-JOCHJYFZSA-N
Associated Targets(non-human)
Mitogen-activated protein kinase 3 111 Activities
MAP kinase ERK2 650 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 507.56 | Molecular Weight (Monoisotopic): 507.2246 | AlogP: 5.39 | #Rotatable Bonds: 6 |
| Polar Surface Area: 73.91 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 13.21 | CX Basic pKa: 7.26 | CX LogP: 4.69 | CX LogD: 4.46 |
| Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.37 | Np Likeness Score: -1.60 |
References
| 1. (2015) Heterocyclic compounds as ERK inhibitors, |
Source
Source(1):